Invacare Corp . (NYSE:IVC) reported Q2 EPS of ($0.62), $0.19 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $189 million versus the consensus estimate of $212.19 million.
Invacare Corp . (NYSE:IVC) reported Q2 EPS of ($0.62), $0.19 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $189 million versus the consensus estimate of $212.19 million.